Literature DB >> 22905345

Disulfide linkage: a potent strategy in tumor-targeting drug discovery.

J Wang1, S Li, T Luo, C Wang, J Zhao.   

Abstract

Targeted drug delivery has attracted much attention in improving the curative effect of existing chemotherapy drugs, and many published studies have suggested the disulfide linkage for key unit in constructing a targeting conjugate. An appropriate disulfide bond,through which cytotoxic agents and drug carriers were linked together, would guarantee the conjugate stable during circulation in vivo and, readily cleavable to release the drug. The aim of this article is to review various design strategies based on disulfide linkage which have been used to assemble a tumor-targeting conjugate, with the goal of presenting a promising avenue in the field of targeted drug delivery.

Entities:  

Mesh:

Substances:

Year:  2012        PMID: 22905345     DOI: 10.2174/092986712800672030

Source DB:  PubMed          Journal:  Curr Med Chem        ISSN: 0929-8673            Impact factor:   4.530


  5 in total

1.  Facile Fabrication of Tumor Redox-Sensitive Nanoassemblies of Small-Molecule Oleate Prodrug as Potent Chemotherapeutic Nanomedicine.

Authors:  Cong Luo; Jin Sun; Bingjun Sun; Dan Liu; Lei Miao; Tyler Jay Goodwin; Leaf Huang; Zhonggui He
Journal:  Small       Date:  2016-09-30       Impact factor: 13.281

2.  Stabilized Polymer Micelles for the Development of IT-147, an Epothilone D Drug-Loaded Formulation.

Authors:  Adam Carie; Bradford Sullivan; Tyler Ellis; J Edward Semple; Taylor Buley; Tara Lee Costich; Richard Crouse; Suzanne Bakewell; Kevin Sill
Journal:  J Drug Deliv       Date:  2016-12-01

Review 3.  Linkers: An Assurance for Controlled Delivery of Antibody-Drug Conjugate.

Authors:  Rotimi Sheyi; Beatriz G de la Torre; Fernando Albericio
Journal:  Pharmaceutics       Date:  2022-02-11       Impact factor: 6.321

Review 4.  Peptide-Drug Conjugates and Their Targets in Advanced Cancer Therapies.

Authors:  Paul Hoppenz; Sylvia Els-Heindl; Annette G Beck-Sickinger
Journal:  Front Chem       Date:  2020-07-07       Impact factor: 5.221

5.  Albumin-Methotrexate Prodrug Analogues That Undergo Intracellular Reactivation Following Entrance into Cancerous Glioma Cells.

Authors:  Itzik Cooper; Michal Schnaider-Beeri; Mati Fridkin; Yoram Shechter
Journal:  Pharmaceutics       Date:  2021-12-28       Impact factor: 6.321

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.